Skip to main navigation

About
our medicine
science & pipeline
Patients
healthcare professionals
Investors
Careers

About
our medicine
science & pipeline
Patients
healthcare professionals
Investors
Careers

News Releases

Year

August 28, 2024

PDF Version

X4 Pharmaceuticals to Participate in Upcoming September Investor Conferences

August 8, 2024

PDF Version

X4 Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Corporate Updates

August 1, 2024

PDF Version

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

July 30, 2024

PDF Version

X4 Pharmaceuticals to Report Second Quarter 2024 Financial Results and Host a Conference Call and Webcast on August 8, 2024

June 27, 2024

PDF Version

X4 Pharmaceuticals Announces Positive Interim Clinical Data from Ongoing Six-Month Phase 2 Trial of Mavorixafor in Chronic Neutropenia (CN) and Initiation of Pivotal Phase 3 CN Trial

June 3, 2024

PDF Version

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 29, 2024

PDF Version

X4 Pharmaceuticals to Host Virtual Investor Event on June 27, 2024 to Review New Mavorixafor Clinical Data from Ongoing Phase 2 Trial in Chronic Neutropenia

May 13, 2024

PDF Version

X4 Pharmaceuticals to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference

May 9, 2024

PDF Version

X4 Pharmaceuticals Announces $125 Million Capital Infusion from $105 Million Sale of Priority Review Voucher and $20 Million Drawdown from Existing Loan Facility

May 7, 2024

PDF Version

X4 Pharmaceuticals Reports First-Quarter 2024 Financial Results and Provides Corporate Updates

Pagination

First page
Previous page
Page 1
Current page 2
Page 3
Next page
Last page

Displaying 11 - 20 of 29

quick links

Quick Links

About
Patients
Investors
Careers

contact

X4 Pharmaceuticals
61 North Beacon Street
4th Floor
Boston, MA 02134 Phone: 857.529.8300

X4 Pharmaceuticals (Austria) GmbH
Helmut-Qualtinger-Gasse 2
A-103 Vienna, Austria Phone: +43.1.395078300

© 2024 X4 Pharmaceuticals, Inc. All rights reserved.

Live - Footer

Terms of Use | Privacy | Compliance and Ethics